Search results
Results From The WOW.Com Content Network
A leprostatic agent is a drug that interferes with proliferation of the bacterium that causes leprosy. [1] [2] The following agents are leprostatic agents: [3] acedapsone; clofazimine; dapsone; desoxyfructo-serotonin; diucifon; ethionamide; rifampicin; rifapentine; sulfameter; thalidomide; Leprosy is a chronic infectious disease caused by ...
Leprosy has historically been associated with social stigma, which continues to be a barrier to self-reporting and early treatment. [4] Leprosy is classified as a neglected tropical disease. [21] World Leprosy Day was started in 1954 to draw awareness to those affected by leprosy. [22] [4] The study of leprosy and its treatment is known as ...
Do not sleep with the patients, as the disease is transmittable to those nearby." This was the first document concerning believed infectious aspect of the disease. [60] Japan passed leprosy prevention laws in 1907, 1931, and 1953 that were based on segregation of persons with the disease; this approach intensified leprosy stigma. Lepers were ...
Mycobacterium leprae (also known as the leprosy bacillus or Hansen's bacillus) is one [a] of the two species of bacteria that cause Hansen's disease (leprosy), [1] a chronic but curable infectious disease that damages the peripheral nerves and targets the skin, eyes, nose, and muscles.
Leprosy, sometimes known as Hansen's disease, is an infectious disease caused by Mycobacterium leprae, an aerobic, acid-fast, rod-shaped mycobacterium. The modern term for the disease is named after the discoverer of the bacterium, Gerhard Armauer Hansen .
Hansen remained medical officer for leprosy in Norway and it was through his efforts that the leprosy acts of 1877 and 1885 were passed, leading to a steady decline of the disease in Norway from 1,800 known cases in 1875 to just 575 cases in 1901. Hansen had had syphilis since the 1860s but died of heart disease. He was an atheist. [10] [11]
National Leprosy Eradication Program is a health scheme of the Ministry of Health and Family Welfare, Government of India to eradicate leprosy in India. [1] It was launched in 1983 as a continuation of the National Leprosy Control Program of 1955.
Mycobacterium lepromatosis can induce diffuse lepromatous leprosy (DLL), typically known to occur in Mexico and the Caribbean. [5] [6] DLL is a severe form of leprosy which manifests through nerve invasion and extensive skin ulcerations due to massive AFB burden in internal organs. [5]